Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial

🏭 Genentech’s new $750M factory: Roche’s Genentech is investing $750 million in a new drug delivery device facility at its site in Hillsboro, OR, which is expected to be operational in ...